**RC Pharmacy** is a modern enterprise that has been operating since 1993. The company specializes in the integration of research and development, production, and sales of contemporary Chinese medicine and biological drugs. Its recent Series A investment on 16th March 2020 attracted a noteworthy group of investors, including **Lilly Asia Ventures, OrbiMed, Vivo Capital, Janchor Partners, Lake Bleu Capital (Hong Kong) Limited**, and **Hudson Bay Capital Management**. With a focus on the Health Care and Pharmaceutical industries, RC Pharmacy continues to expand its presence in the market, leveraging its expertise in modern Chinese medicine and biological drugs.
No recent news or press coverage available for RC Pharmacy.